91 related articles for article (PubMed ID: 8225871)
1. Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.
Kan-Mitchell J; Liggett PE; Taylor CR; Rao N; Granada ES; Danenberg KD; White WL; Van Eldik LJ; Horikoshi T; Danenberg PV
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3366-75. PubMed ID: 8225871
[TBL] [Abstract][Full Text] [Related]
2. S100 immunophenotypes of uveal melanomas.
Kan-Mitchell J; Rao N; Albert DM; Van Eldik LJ; Taylor CR
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1492-6. PubMed ID: 1696942
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
4. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.
Daniels KJ; Boldt HC; Martin JA; Gardner LM; Meyer M; Folberg R
Lab Invest; 1996 Jul; 75(1):55-66. PubMed ID: 8683940
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in expression of S100 beta mRNA in human melanoma and pleomorphic adenoma demonstrated by in situ hybridization.
Landry CF; Kahn HJ; Baumal R; Marks A; Brown IR
Am J Pathol; 1991 Nov; 139(5):1151-6. PubMed ID: 1659204
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
7. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
Zeuthen J; Birck A; Straten PT
Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
[TBL] [Abstract][Full Text] [Related]
8. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.
Béliveau A; Bérubé M; Rousseau A; Pelletier G; Guérin SL
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2363-72. PubMed ID: 10892885
[TBL] [Abstract][Full Text] [Related]
9. Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy.
Kumagai K; Nimura Y; Mizota A; Miyahara N; Aoki M; Furusawa Y; Takiguchi M; Yamamoto S; Seki N
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2300-4. PubMed ID: 16723437
[TBL] [Abstract][Full Text] [Related]
10. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
[TBL] [Abstract][Full Text] [Related]
13. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
[TBL] [Abstract][Full Text] [Related]
14. Expression of retina-specific genes by mouse retinoblastoma cells.
Bernstein SL; Kutty G; Wiggert B; Albert DM; Nickerson JM
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3931-7. PubMed ID: 7928191
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display.
Hashimoto Y; Shindo-Okada N; Tani M; Takeuchi K; Toma H; Yokota J
Cancer Res; 1996 Nov; 56(22):5266-71. PubMed ID: 8912867
[TBL] [Abstract][Full Text] [Related]
18. Expression of calcyclin in human melanocytic lesions.
Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ
Cancer Res; 1993 Dec; 53(24):6061-6. PubMed ID: 8261423
[TBL] [Abstract][Full Text] [Related]
19. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
20. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
Tobal K; Sherman LS; Foss AJ; Lightman SL
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
